X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21039) 21039
Publication (1512) 1512
Newsletter (174) 174
Book Chapter (143) 143
Book Review (127) 127
Dissertation (41) 41
Magazine Article (31) 31
Conference Proceeding (30) 30
Book / eBook (7) 7
Reference (5) 5
Government Document (4) 4
Journal / eJournal (2) 2
Trade Publication Article (2) 2
Data Set (1) 1
Newspaper Article (1) 1
Paper (1) 1
Presentation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (12930) 12930
female (7111) 7111
male (6873) 6873
animals (6852) 6852
oncology (5490) 5490
index medicus (5464) 5464
middle aged (4077) 4077
antineoplastic agents, alkylating - therapeutic use (4028) 4028
adult (3678) 3678
mice (3215) 3215
alkylating agents (3102) 3102
aged (3099) 3099
chemotherapy (2925) 2925
antineoplastic agents, alkylating - administration & dosage (2834) 2834
cancer (2585) 2585
alkylating agents - pharmacology (2395) 2395
antineoplastic agents, alkylating - pharmacology (2372) 2372
dacarbazine - analogs & derivatives (2371) 2371
alkylating-agents (2122) 2122
treatment outcome (2108) 2108
rats (2019) 2019
antineoplastic agents, alkylating - adverse effects (1951) 1951
pharmacology & pharmacy (1726) 1726
temozolomide (1689) 1689
combined modality therapy (1529) 1529
dacarbazine - therapeutic use (1479) 1479
dose-response relationship, drug (1461) 1461
biochemistry & molecular biology (1418) 1418
cyclophosphamide (1376) 1376
brain neoplasms - drug therapy (1352) 1352
antineoplastic combined chemotherapy protocols - therapeutic use (1350) 1350
toxicology (1300) 1300
cell line, tumor (1299) 1299
time factors (1293) 1293
dna repair (1251) 1251
alkylating agents - therapeutic use (1230) 1230
hematology (1196) 1196
adolescent (1190) 1190
dna damage (1179) 1179
dna (1141) 1141
alkylating agents - toxicity (1127) 1127
research (1124) 1124
retrospective studies (1124) 1124
therapy (1069) 1069
apoptosis (1063) 1063
radiotherapy (1056) 1056
care and treatment (1013) 1013
cyclophosphamide - administration & dosage (992) 992
analysis (976) 976
child (967) 967
prognosis (963) 963
antineoplastic agents (948) 948
alkylation (943) 943
aged, 80 and over (941) 941
glioblastoma (936) 936
expression (920) 920
tumor cells, cultured (896) 896
surgery (885) 885
follow-up studies (879) 879
antineoplastic agents - therapeutic use (874) 874
alkylating agents - administration & dosage (862) 862
cyclophosphamide - therapeutic use (862) 862
mutation (859) 859
medicine & public health (857) 857
genetics & heredity (855) 855
cell survival - drug effects (853) 853
clinical neurology (851) 851
tumors (847) 847
glioblastoma - drug therapy (835) 835
antineoplastic agents - pharmacology (814) 814
survival (775) 775
disease-free survival (773) 773
neoplasms - drug therapy (767) 767
apoptosis - drug effects (762) 762
cells (738) 738
toxicity (713) 713
dacarbazine - pharmacology (703) 703
survival analysis (702) 702
survival rate (691) 691
brain neoplasms - pathology (674) 674
article (673) 673
chemistry, medicinal (665) 665
melphalan - administration & dosage (649) 649
kinetics (645) 645
glioma - drug therapy (639) 639
child, preschool (636) 636
antimitotic agents (630) 630
cell line (630) 630
dna - metabolism (621) 621
antineoplastic agents, alkylating - toxicity (619) 619
drug resistance (618) 618
drug administration schedule (615) 615
young adult (606) 606
transplantation (599) 599
melphalan (595) 595
ophthalmology (591) 591
cell biology (588) 588
health aspects (581) 581
antineoplastic agents, alkylating - pharmacokinetics (580) 580
structure-activity relationship (578) 578
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19822) 19822
Russian (396) 396
German (324) 324
French (305) 305
Japanese (192) 192
Chinese (105) 105
Italian (52) 52
Polish (52) 52
Spanish (51) 51
Hungarian (20) 20
Czech (19) 19
Norwegian (11) 11
Portuguese (11) 11
Ukrainian (11) 11
Dutch (7) 7
Korean (7) 7
Bulgarian (6) 6
Finnish (6) 6
Swedish (6) 6
Hebrew (5) 5
Serbian (5) 5
Croatian (4) 4
Danish (4) 4
Lithuanian (4) 4
Slovak (2) 2
Romanian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 8/2011, Volume 68, Issue 2, pp. 445 - 455
The natural flavonoid fisetin was recently identified as a lead compound that stabilizes endothelial cell microtubules. In this study, we investigated the... 
Fisetin | Lewis lung carcinoma | Angiogenesis | Antitumour activity | Cyclophosphamide | Medicine & Public Health | Cancer Research | Oncology | Cytotoxicity | EA·hy 926 endothelial cells | Pharmacology/Toxicology | Flavonoid | EA•hy 926 endothelial cells | APOPTOSIS | ANTIINFLAMMATORY ACTIVITY | ACTIVATION | CELL-CYCLE ARREST | PROLIFERATION | METASTATIC COLORECTAL-CANCER | IN-VITRO | ONCOLOGY | ENDOTHELIAL-CELLS | PHARMACOLOGY & PHARMACY | EA.hy 926 endothelial cells | INHIBITORS | NIH 3T3 Cells | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Tubulin Modulators - pharmacology | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antineoplastic Agents, Alkylating - pharmacology | Flavonoids - adverse effects | Antineoplastic Agents, Alkylating - administration & dosage | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Flavonoids - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Angiogenesis Inhibitors - administration & dosage | Antineoplastic Agents, Phytogenic - administration & dosage | Angiogenesis Inhibitors - therapeutic use | Flavonoids - administration & dosage | Tubulin Modulators - administration & dosage | Female | Flavonoids - pharmacology | Antineoplastic Agents, Phytogenic - therapeutic use | Angiogenesis Inhibitors - adverse effects | Antineoplastic Agents, Phytogenic - adverse effects | Cell Line | Cell Survival - drug effects | Tubulin Modulators - adverse effects | Mice, Inbred C57BL | Angiogenesis Inhibitors - pharmacology | Tubulin Modulators - therapeutic use | Carcinoma, Lewis Lung - drug therapy | Antineoplastic Agents, Alkylating - therapeutic use | Cell Movement - drug effects | Animals | Tumor Burden - drug effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Endothelial Cells - cytology | Neovascularization, Pathologic - drug therapy | Cyclophosphamide - pharmacology | Carcinoma, Lewis Lung - pathology | Cell Proliferation - drug effects | Mice | Antineoplastic Agents, Alkylating - adverse effects | Antineoplastic Agents, Phytogenic - pharmacology | Cell Cycle - drug effects | Endothelial Cells - drug effects | Antimitotic agents | Flavonoids | Flavones | Lung cancer | Bioflavonoids | Accountants | Drug therapy, Combination | Universities and colleges | Antineoplastic agents | Endothelium | Tumors | Index Medicus | cytology | Antineoplastic Agents, Phytogenic | pathology | Cell Proliferation | Endothelial Cells | Tubulin Modulators | Neovascularization, Pathologic | fisetin | administration & dosage | pharmacology | flavonoid | Carcinoma, Lewis Lung | Antineoplastic Agents, Alkylating | cytotoxicity | drug therapy | Cell Survival | angiogenesis | Antineoplastic Combined Chemotherapy Protocols | drug effects | Tumor Burden | Angiogenesis Inhibitors | EA.hy 926 | Cell Cycle | antitumour activity | adverse effects | therapeutic use | Cell Movement
Journal Article
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 01/2014, Volume 61, Issue 1, pp. 53 - 67
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 12/2016, Volume 15, Issue 12, pp. 3000 - 3014
Journal Article
Materials Science & Engineering C, ISSN 0928-4931, 04/2016, Volume 61, pp. 1002 - 1017
Small molecules that bind genomic DNA have proven that they can be effective anticancer, antibiotic and antiviral therapeutic agents that affect the well-being... 
Drug discovery | DNA hybridization | Drug–DNA interaction | DNA damage | Electrochemical DNA biosensor | Pharmacogenomics | Drug-DNA interaction | MATERIALS SCIENCE, BIOMATERIALS | ANTICANCER DRUG | SITU ELECTROCHEMICAL EVALUATION | DOUBLE-STRANDED DNA | CARBON NANOTUBES | WASTE-WATER SAMPLES | BREAST-CANCER | PENCIL GRAPHITE ELECTRODE | SURFACE-CONFINED DNA | CYCLIC VOLTAMMETRY | ACTIVATED MITOMYCIN-C | Anti-Bacterial Agents - analysis | Pharmacogenetics | Electrochemical Techniques | Alkylating Agents - pharmacology | Humans | Anti-Bacterial Agents - metabolism | Antineoplastic Agents - analysis | Intercalating Agents - pharmacology | DNA - metabolism | DNA Cleavage - drug effects | Alkylating Agents - metabolism | DNA - chemistry | Intercalating Agents - metabolism | Pharmaceutical Preparations - metabolism | DNA - analysis | Biosensing Techniques | Pharmaceutical Preparations - chemistry | Alkylating Agents - analysis | Nanostructures - chemistry | Anti-Bacterial Agents - pharmacology | Antineoplastic Agents - pharmacology | Intercalating Agents - analysis | Pharmaceutical Preparations - analysis | Antiviral agents | Usage | DNA replication | Drug interactions | DNA | Genetic research | Electrochemistry | Electric properties | Drugs | Deoxyribonucleic acid | Strands | Materials science | Nanostructure | Cognition | Biosensors | Binding sites
Journal Article
Journal of the American Chemical Society, ISSN 0002-7863, 12/2011, Volume 133, Issue 48, pp. 19278 - 19281